false
OasisLMS
Catalog
SCCM Resource Library
Is Renin the New Lactate for Tissue Perfusion and ...
Is Renin the New Lactate for Tissue Perfusion and Prognosis?
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In this video, Ashish Khanna discusses the use of renin in critically ill patients for tissue perfusion and prognosis. He explains that the renin-angiotensin system, along with the sympathetic nervous system and arginine vasopressin, is involved in regulating blood pressure in these patients. He discusses studies that have shown the effectiveness of angiotensin II in treating shock and improving hemodynamic stability. Khanna also explains how ACE, the enzyme that converts angiotensin I to angiotensin II, is impaired in conditions like acute lung injury, leading to a disruption in the renin-angiotensin system. He discusses the non-classical pathway of angiotensin metabolism and the role of renin in predicting tissue perfusion and mortality in critically ill patients, suggesting that renin may be a better marker than lactate. Khanna also presents data showing the benefits of angiotensin II treatment and the association between renin levels and mortality. He concludes by mentioning the need for strategies to reduce the use of catecholamines in critically ill patients and highlights ongoing research in this area.
Asset Subtitle
Sepsis, Infection, 2022
Asset Caption
This session will review traditional and new biomarkers in the setting of COVID-19, sepsis, and post-cardiac arrest.
Meta Tag
Content Type
Presentation
Knowledge Area
Sepsis
Knowledge Area
Infection
Knowledge Level
Intermediate
Knowledge Level
Advanced
Learning Pathway
Sepsis Resources
Membership Level
Select
Tag
Sepsis
Tag
COVID-19
Year
2022
Keywords
renin
critically ill patients
tissue perfusion
mortality prediction
angiotensin II treatment benefits
Sepsis
Infection
Sepsis
Presentation
Select
2022
COVID-19
Intermediate
Advanced
Sepsis Resources
×
Please select your language
1
English